Related references
Note: Only part of the references are listed.Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression
Yuan Fang et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease
Yue Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Role and Possible Mechanisms of Sirt1 in Depression
Guofang Lu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models
Mariah L. Hoye et al.
JOURNAL OF NEUROSCIENCE (2017)
MicroRNA epigenetic signatures in human disease
Klara Piletic et al.
ARCHIVES OF TOXICOLOGY (2016)
Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior
Naoko Abe-Higuchi et al.
BIOLOGICAL PSYCHIATRY (2016)
SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model
Siqi Xu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
All Roads Lead to the miRNome: miRNAs Have a Central Role in the Molecular Pathophysiology of Psychiatric Disorders
Richard M. O'Connor et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1
Xiaoyi Li et al.
SCIENTIFIC REPORTS (2016)
Sparse whole-genome sequencing identifies two loci for major depressive disorder
Na Cai et al.
NATURE (2015)
Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice
Syed Hamid Ali et al.
STEROIDS (2015)
Identification of Differential MicroRNAs in Cerebrospinal Fluid and Serum of Patients with Major Depressive Disorder
Yunqiang Wan et al.
PLOS ONE (2015)
Resveratrol activates SIRT1 in a Lamin A-dependent manner
Shrestha Ghosh et al.
CELL CYCLE (2013)
Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
Fatih Arslan et al.
STEM CELL RESEARCH (2013)
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers
Keren Oved et al.
PHARMACOGENOMICS (2012)
Targeting cardiovascular disease with novel SIRT1 pathways
Zhao Zhong Chong et al.
FUTURE CARDIOLOGY (2012)
Neural mechanisms of the cognitive model of depression
Seth G. Disner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity
Takeshi Yoshizaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
SIRT1 gene is associated with major depressive disorder in the Japanese population
Taro Kishi et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
Nils Habbe et al.
CANCER BIOLOGY & THERAPY (2009)
miR-155: On the Crosstalk Between Inflammation and Cancer
Esmerina Tili et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
Ron Firestein et al.
PLOS ONE (2008)
SIRT1 is significantly elevated in mouse and human prostate cancer
Derek M. Huffman et al.
CANCER RESEARCH (2007)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Share Paper
